Search by Drug Name or NDC

    NDC 72789-0174-01 Lithium Carbonate 300 mg/1 Details

    Lithium Carbonate 300 mg/1

    Lithium Carbonate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is LITHIUM CARBONATE.

    Product Information

    NDC 72789-0174
    Product ID 72789-174_f49a9e84-4baa-068e-e053-2a95a90a6e4d
    Associated GPIs 59500010100305
    GCN Sequence Number 004003
    GCN Sequence Number Description lithium carbonate TABLET 300 MG ORAL
    HIC3 H2M
    HIC3 Description BIPOLAR DISORDER DRUGS
    GCN 15721
    HICL Sequence Number 001669
    HICL Sequence Number Description LITHIUM CARBONATE
    Brand/Generic Generic
    Proprietary Name Lithium Carbonate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lithium Carbonate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name LITHIUM CARBONATE
    Labeler Name PD-Rx Pharmaceuticals, Inc.
    Pharmaceutical Class Mood Stabilizer [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA018558
    Listing Certified Through 2024-12-31

    Package

    NDC 72789-0174-01 (72789017401)

    NDC Package Code 72789-174-01
    Billing NDC 72789017401
    Package 100 TABLET in 1 BOTTLE, PLASTIC (72789-174-01)
    Marketing Start Date 2021-03-09
    NDC Exclude Flag N
    Pricing Information N/A